FG Begins Payment Of Delayed BEA Scholarship Allowances

  The Federal Government has commenced disbursement of outstanding 2025 allowances owed to Nigerian students benefiting from the Bilateral Education Agreement Scholarship Programme in partner countries, offering long-awaited financial relief to scholars who have endured months of hardship due to payment delays. The development was disclosed in an official statement issued on Wednesday by the…

Read More

Kwankwaso: Obi Popular Across South, North

  Former Kano State Governor Rabiu Kwankwaso has described former Labour Party presidential candidate Peter Obi as a popular politician across southern Nigeria and many parts of the north, while claiming that his political movement delivered about two million votes for Obi during the 2023 election cycle. Mr Kwankwaso made the remarks in an interview…

Read More

Taiwan Rejects Trump Warning on Independence

  Hours after US President Donald Trump cautioned Taiwan against declaring formal independence, the island’s government pushed back firmly, insisting it already is one. Taiwan’s foreign ministry issued a direct statement on Saturday declaring that Taiwan “is a sovereign and independent democratic nation, and is not subordinate to the People’s Republic of China.” The statement…

Read More

EFCC Arraigns Blessing CEO Over Alleged N36m Fraud

  Popular social media influencer and self-styled relationship therapist Okoro Blessing Nkiruka, widely known as Blessing CEO, was on Friday arraigned before a Federal High Court in Ikoyi, Lagos, over an alleged N36 million fraud involving a property lease transaction. The Lagos Zonal Directorate 1 of the Economic and Financial Crimes Commission brought the defendant…

Read More

South Africa to Manufacture Twice-Yearly HIV Prevention Drug

    A South African laboratory is set to produce a generic version of lenacapavir, a revolutionary twice-yearly HIV injection, marking a significant milestone in Africa’s push toward pharmaceutical self-sufficiency, global health agency Unitaid announced on Tuesday. Lenacapavir, originally developed by American pharmaceutical giant Gilead Sciences, has drawn widespread medical attention for its exceptional efficacy….

Read More